8010, 8011, 8013, 8014 | Moska Hellamand | Access To Medicine Foundation, Netherlands | Assessment of datasets shared on the AMR Register | GSK, Johnson & Johnson, Pfizer, Shionogi |
8055 | Jose Lopez Revilla | Instituto Nacional de salud del Niño San Borja, Peru | The impact of resistance on sepsis mortality in pediatrics | Pfizer |
8173 | Catrin Moore | St George's, University of London, UK | ADILA (AMR data for local action) | GSK, Johnson & Johnson, Paratek, Pfizer, Shionogi, Venatorx |
8235 | Megan Coffee | Mailman School of Public Health, USA | Nigeria AMR | Pfizer, Shionogi, Venatorx |
8430 | Victoria Savage | Infex Therapeutics, UK | Establishing the prevalence of metallo-B-lactamases and carbapenem-resistance in Gram negative pathogens | Merck, Pfizer |
8432 | Ghanshyam Lad | Independent researcher, India | The trend of antibiotic resistance of tetracycline in adults in recent years | Pfizer |
8447, 8594, 8595, 8596 | Benn Sartorius | University of Oxford, UK | The Global Research on Antimicrobial Resistance (GRAM) Project | Paratek, Pfizer, Shionogi, Venatorx |
8544 | Gwen Knight | London School of Hygiene and Tropical Medicine, UK | Medical Research Council - Career Development Award (MRC CDA) fellowship project | GSK, Johnson & Johnson, Paratek, Shionogi, Venatorx |
8554 | Ying Huang | The Chinese University of Hong Kong, China | To explore pathogens and antibiotic susceptibility in hospital | Pfizer |
8612/8613 | Camille Andre | Harvard Medical School, USA | Epidemiology and antimicrobial resistance of bacteria causing eye infections | Paratek, Pfizer |
8745 | Ingrid Jacobson | University of Minnesota Twin Cities - Center for Infectious Disease Research and Prevention (CIDRAP), USA | Master's Thesis Project on Antifungal Resistance | Pfizer |
8811 | Naomi Waterlow | London School of Hygiene and Tropical Medicine, UK | AMR and age | GSK, Johnson & Johnson, Paratek, Pfizer, Venatorx |